We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

228 hedge funds and large institutions have $4.71B invested in Amicus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 98 increasing their positions, 64 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

358% more call options, than puts

Call options by funds: $51.8M | Put options by funds: $11.3M

53% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 64

30% more capital invested

Capital invested by funds: $3.63B → $4.71B (+$1.08B)

14% more funds holding in top 10

Funds holding in top 10: 7 → 8 (+1)

10% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 29

9.28% more ownership

Funds ownership: 104.03% → 113.31% (+9.3%)

0% more funds holding

Funds holding: 228 → 228 (0)

Holders
228
Holders Change
–
Holders Change %
0%
% of All Funds
3.32%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.12%
New
32
Increased
98
Reduced
64
Closed
29
Calls
$51.8M
Puts
$11.3M
Net Calls
+$40.5M
Net Calls Change
+$36M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$181M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$87M
3
Deutsche Bank
Deutsche Bank
Germany
+$63.9M
4
JP Morgan Chase
JP Morgan Chase
New York
+$54.9M
5
Blackstone Inc
Blackstone Inc
New York
+$28M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$38.9M
2
BC
Boxer Capital
California
-$28.3M
3
RG
Redmile Group
California
-$24M
4
AG
Artal Group
Luxembourg
-$23.1M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$20.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
226
Huntington National Bank
Ohio
$823 +$647 +57 +5,700%
GRP
227
Global Retirement Partners
California
$585 +$522 +46 New
VCM
228
Versant Capital Management
Arizona
$397 +$318 +28 New
BC
229
Boxer Capital
California
– -$28.3M -2,325,000 Closed
Point72 Asset Management
230
Point72 Asset Management
Connecticut
– -$11.5M -946,697 Closed
AA
231
ALPS Advisors
Colorado
– -$2.58M -211,895 Closed
GTC
232
Ghost Tree Capital
New York
– -$2.13M -175,000 Closed
Walleye Capital
233
Walleye Capital
New York
– -$2.09M -172,169 Closed
SG Americas Securities
234
SG Americas Securities
New York
– -$1.52M -125,014 Closed
Squarepoint
235
Squarepoint
New York
– -$1.51M -123,919 Closed
CPC
236
Cookson Peirce & Co
Pennsylvania
– -$767K -63,058 Closed
Marshall Wace
237
Marshall Wace
United Kingdom
– -$755K -62,114 Closed
TI
238
Trexquant Investment
Connecticut
– -$729K -59,976 Closed
Walleye Trading
239
Walleye Trading
New York
– -$528K -46,474 Closed
GCM
240
Graham Capital Management
Connecticut
– -$556K -45,685 Closed
GS
241
GTS Securities
New York
– -$499K -43,932 Closed
ACM
242
Aquatic Capital Management
Illinois
– -$516K -42,400 Closed
AIM
243
Aigen Investment Management
New York
– -$385K -31,695 Closed
YIH
244
Y-Intercept (HK)
Hong Kong
– -$294K -24,170 Closed
SCM
245
SevenOneSeven Capital Management
Pennsylvania
– -$246K -23,989 Closed
ETC
246
Exchange Traded Concepts
Oklahoma
– -$260K -21,373 Closed
NRD
247
Nebula Research & Development
New York
– -$247K -20,280 Closed
EFMC
248
Empire Financial Management Company
New York
– -$243K -20,000 Closed
MM
249
MQS Management
New York
– -$242K -19,905 Closed
VPIM
250
Vanguard Personalized Indexing Management
California
– -$182K -14,995 Closed
7 8 9
10
11

FOLD Hedge Fund Activity: Q4 2023 in Review

228 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2023, worth a combined $4.71B — up 30% from $3.63B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new FOLD positions and 29 closed out — a net gain of 3 holders — while 98 added to existing stakes and 64 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $181M. The largest seller was Janus Henderson Group, cutting an estimated $38.9M.

  • 228 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $4.71B of Amicus Therapeutics stock for Q4 2023, up 30% quarter-over-quarter.
  • 32 funds opened new Amicus Therapeutics positions in Q4 2023 and 29 closed out, a net change of +3 holders.
  • The largest Amicus Therapeutics buyer in Q4 2023 was Morgan Stanley, an estimated $181M added.
  • The largest Amicus Therapeutics seller in Q4 2023 was Janus Henderson Group, an estimated $38.9M sold.

Based on aggregated 13F filings for Q4 2023.